Health-related quality of life and financial impact of caring for a child with Thalassaemia Major in the UK

Child Care Health Dev. 2010 Jan;36(1):118-22. doi: 10.1111/j.1365-2214.2009.01043.x. Epub 2009 Nov 30.

Abstract

Background: Thalassaemia Major (TM) is a serious condition characterized by life-long dependence on blood transfusions and chelation therapy. Our aim was to determine health-related quality of life (HRQOL) in children with TM living in the UK, and the impact of caring for a child receiving National Health Service treatment on family finances.

Methods: This was a cross-sectional assessment of HRQOL in children (n= 22) with TM aged 8-18 years. Children were recruited from three UK Paediatric Haematology and Bone Marrow Transplant centres. Mothers completed measures of their child's HRQOL [PedsQL 4.0 (Measurement Model for the Pediatric Quality of Life Inventory, James W. Varni PhD, PedMetrics, Quantifying the Qualitative SM, Copyright 1998-2009)] and behaviour (Strengths and Difficulties questionnaire), and the impact of caring for the child on family finances.

Results: Child behaviour was within the normal range but child HRQOL was significantly lower than population norms. Family financial concerns associated with TM were associated with poorer child HRQOL (P= 0.020).

Conclusions: Thalassaemia Major poses a considerable challenge to child HRQOL, well documented in areas of the world where TM is prevalent. Despite the availability of National Health Service care and financial benefits our study suggests a similar burden in the UK.

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Cost of Illness*
  • Family
  • Female
  • Health Status*
  • Humans
  • Male
  • Middle Aged
  • Quality of Life*
  • Social Support
  • Surveys and Questionnaires
  • United Kingdom
  • beta-Thalassemia / economics*
  • beta-Thalassemia / psychology*
  • beta-Thalassemia / therapy